IRIS
CERNARO, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.125
NA - Nord America 5.151
AS - Asia 3.170
SA - Sud America 968
AF - Africa 105
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.024
RU - Federazione Russa 3.467
SG - Singapore 1.249
CN - Cina 950
BR - Brasile 827
IE - Irlanda 707
SE - Svezia 595
HK - Hong Kong 344
IT - Italia 322
DE - Germania 251
VN - Vietnam 194
FR - Francia 183
PL - Polonia 170
GB - Regno Unito 139
IN - India 123
FI - Finlandia 113
CA - Canada 56
AR - Argentina 54
TR - Turchia 50
BD - Bangladesh 44
MX - Messico 44
ZA - Sudafrica 34
EC - Ecuador 28
IQ - Iraq 27
BE - Belgio 24
PK - Pakistan 24
NL - Olanda 22
ES - Italia 21
CZ - Repubblica Ceca 20
ID - Indonesia 20
JP - Giappone 20
UZ - Uzbekistan 19
AT - Austria 17
CO - Colombia 17
UA - Ucraina 17
KE - Kenya 16
MA - Marocco 13
VE - Venezuela 13
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
AU - Australia 9
AZ - Azerbaigian 9
EG - Egitto 9
PY - Paraguay 9
CH - Svizzera 8
KG - Kirghizistan 8
CI - Costa d'Avorio 7
CL - Cile 7
IL - Israele 7
JM - Giamaica 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
AL - Albania 5
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
MY - Malesia 5
NO - Norvegia 5
PS - Palestinian Territory 5
BG - Bulgaria 4
DK - Danimarca 4
HN - Honduras 4
JO - Giordania 4
LT - Lituania 4
LV - Lettonia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
RO - Romania 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
BN - Brunei Darussalam 2
BO - Bolivia 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
KZ - Kazakistan 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GI - Gibilterra 1
GT - Guatemala 1
Totale 15.521
Salva come PNG Salva come JPEG
Città #
Moscow 951
Ashburn 911
Dublin 705
Dallas 692
Singapore 688
Chandler 572
Hong Kong 341
Nyköping 332
Beijing 320
San Jose 207
The Dalles 161
Warsaw 157
New York 150
Los Angeles 135
Munich 113
Dearborn 111
Boardman 108
Princeton 104
Jacksonville 101
Lauterbourg 95
Medford 93
Ann Arbor 90
Messina 79
Des Moines 74
Cambridge 72
São Paulo 68
Ho Chi Minh City 64
Jinan 55
Shenyang 49
Tianjin 49
Bremen 44
Houston 44
Redondo Beach 44
Frankfurt am Main 41
Hanoi 41
Hyderabad 40
Buffalo 39
San Mateo 39
Turku 37
Orem 34
Pune 29
Wilmington 28
Lancaster 27
Santa Clara 27
Guangzhou 26
Brooklyn 25
Catania 25
Montreal 25
Seattle 24
Rio de Janeiro 23
Brussels 22
Johannesburg 22
Nanjing 22
Denver 20
Tokyo 20
Council Bluffs 19
Hebei 19
Manchester 19
Mexico City 19
Stockholm 19
Belo Horizonte 18
Chicago 17
Curitiba 17
Poplar 17
Ankara 16
Haikou 16
London 16
Baghdad 15
Brno 15
Hangzhou 15
Ningbo 15
San Francisco 15
Tashkent 15
Brasília 14
Chennai 14
Phoenix 14
Düsseldorf 13
Amsterdam 12
Jiaxing 12
Lentini 12
Nairobi 12
Rome 12
Shanghai 12
Toronto 12
Nuremberg 11
Palermo 11
Taizhou 11
Wroclaw 11
Zhengzhou 11
Campinas 10
Dong Ket 10
Goiânia 10
Guayaquil 10
Jakarta 10
Porto Alegre 10
Portsmouth 10
Salvador 10
Baku 9
Columbus 9
Haiphong 9
Totale 9.018
Salva come PNG Salva come JPEG
Nome #
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 243
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 238
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 230
[From hyponatremia to tolvaptan] 223
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 222
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 221
Auxine: thermodynamic properties, complexing ability and dosage in human serium 216
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 207
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 207
ANTI-INFLAMMATORY ACTION OF DENOSUMAB IN VIVO AND IN VITRO 206
Mortalità e morbidità dei pazienti dializzati in Sicilia: studio epidemiologico analitico sul confronto tra metodiche convettive e diffusive 204
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 195
Sclerostin levels in uremic patients: a link between bone and vascular disease 194
AKI - EXPERIMENTAL MODELS 193
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 191
Down with the erythropoietin. Long live the erythropoietin! 184
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 183
Fibrosis, regeneration and cancer: what is the link? 183
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 177
A new therapy for kidney injury: regeneration. 174
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 174
Beneficial effects of oral pure caffeine on oxidative stress 173
Kidney disease and psoriasis: novel evidences beyond old concepts 172
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 172
Before and after preeclampsia: What biomarkers are there? 168
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 164
Erythropoietin and the truths of science. 163
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 163
The Myth of Water and Salt: From Aquaretics to Tenapanor 163
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 159
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 158
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 157
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 156
Marked improvement of thyroid function and autoimmunity by Aloe barbadensis miller juice in patients with subclinical hypothyroidism 156
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 153
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 153
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 152
Nephro-oncology: a link in evolution 152
COMPARISON OF SEVELAMER, SEVELAMER CARBONATE AND LANTHANIUM CARBONATE IN VITRO AND IN VIVO 150
L’ERITROPOIETINA HA AZIONE NEFROPROTETTIVA IN UN MODELLO SPERIMENTALE DI ZEBRAFISH (DANIO RERIO) DOPO SOMMINISTRAZIONE DI GENTAMICINA 150
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 150
From water to aquaretics: a legendary route. 150
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 148
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 148
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 148
Vascular access for hemodialysis: current perspectives 147
The relationship between coping, emotion regulation, and quality of life of patients on dialysis 147
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 146
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 145
Erithropoietin exerts a renoprotective action in an experimental model of zebrafish (Danio Rerio) after administration of gentamicin 144
Kidney-lung connections in acute and chronic diseases: current perspectives 144
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 140
CIGARETTE SMOKE AND ENDOTHELIAL DYSFUNCTION: NGAL A NEW BIOMARKER 140
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 140
SCLEROSTIN CAN BE A NEW "KEY PLAYER" IN VASCULARCALCIFICATION IN CKD? 139
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 139
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 137
Regenerative medicine: does Erythropoietin have a role? 137
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 137
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 136
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 135
L'AUXINA INDUCE PROLIFERAZIONE CELLULARE IN UN MODELLO SPERIMENTALE DI CELLULE EPITELIALI TUBULARI RENALI 135
New options for the management of polycystic kidney disease 134
Stress-induced hashitoxicosis: Case report and relative HLA serotype and genotype 134
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis 134
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 133
Novel avenues for treating diabetic nephropathy: new investigational drugs 130
COMPARISON OF FORMULAS TO ESTIMATE THE GLOMERULAR FILTRATION RATE WITH THAT OF SCINTIGRAPHY EVALUATION OF KIDNEY FUNCTION IN HOSPITALIZED PATIENTS 129
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 128
Renal biopsy: Still a landmark for the nephrologist 126
Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion 126
Unexpected hypercalcemia in a diabetic patient with kidney disease 124
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 124
NGAL AND ANESTHETICS: PROTECTIVE ROLE OF SEVOFLURANE 123
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 122
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 122
Role of Vitamin D Status in Diabetic Patients with Renal Disease 121
FP042AUXIN INDUCES CELL PROLIFERATION IN AN EXPERIMENTAL MODEL OF MAMMALIAN RENAL TUBULAR EPITHELIAL CELLS 119
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 118
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 114
Protective role of vitamin d in renal tubulopathies 114
NGAL is a precocious marker of therapeutic response. 113
NEW MARKERS OF VASCULAR AND CARDIAC DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) 110
Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis 108
Autoimmunity and Infection in Glomerular Disease 104
Does Erythropoietin Always Win? 103
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 102
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis 99
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 98
Commonly used immunosuppressive drugs for kidney diseases and pregnancy: focus on open questions 97
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 96
Comparison between creatinine clearance and eGFRcyst-crea: a real-life experience 95
New Insights on the Role of Vitamin D in the Progression of Renal Damage 89
Review and Practical Excursus of the Propensity Score: Low Protein Diet Compared to Mediterranean Diet in Patients With Chronic Kidney Disease 88
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 85
Clinical evaluation of the safety, efficacy and tolerability of lanthanum carbonate in the management of hyperphosphatemia in patients with end-stage renal disease 85
UROTENSIN AND RELAXIN: OPPOSITE ACTIONS AND POTENTIAL THERAPEUTIC APPLICATIONS IN RENAL FIBROSIS 82
The future of phosphate binders: a perspective on novel therapeutics 81
Minimal change disease and focal and segmental glomerulosclerosis: A look at the pathogenesis and new indications from the 2021 KDIGO Guidelines 80
Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor 78
Totale 14.599
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 47 14 17
2021/2022812 13 83 21 48 46 8 50 32 7 171 102 231
2022/20232.054 145 228 87 153 163 189 9 121 877 14 52 16
2023/2024605 37 54 27 42 51 192 18 26 5 59 11 83
2024/20252.555 47 18 50 156 69 106 101 477 603 205 280 443
2025/20268.333 522 531 752 635 775 1.637 972 1.117 1.060 332 0 0
Totale 15.804